LeonaBio, Inc. has filed a Form 8-K with the SEC on March 26, 2026, detailing the results of its operations and financial condition. The filing includes significant disclosures under Item 2.02, which covers the results of operations and financial condition, as well as Item 7.01, which pertains to Regulation FD Disclosure, and Item 9.01, which includes financial statements and exhibits. The company reported its financial results for the period ending on the same date, providing insights into its operational performance and financial health. The filing is part of the company's ongoing commitment to transparency and compliance with regulatory requirements. Investors and stakeholders are encouraged to review the complete filing for detailed information regarding the company's financial metrics and operational strategies. The SEC link to the filing is available for public access, ensuring that all interested parties can stay informed about the company's developments.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.